Compare JPMorgan Chase & Co (JPM) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Chase & Co vs UnitedHealth Group Inc — how do they compare? JPMorgan Chase & Co trades at $339.1 (market cap $900.78B), while UnitedHealth Group Inc trades at $421.62 (market cap $382.83B). The key difference: JPMorgan Chase & Co is far larger — about 2.4× UnitedHealth Group Inc's market cap, and UnitedHealth Group Inc pays the higher dividend (2.2%). Which is the better fit depends on your goals.
| JPM | UNH | |
|---|---|---|
Market Cap | $900.78B | $382.83B |
Volume | 10,479,943 | — |
Sector | Financials | Health |
52-Week High | $346.91 | $431.68 |
52-Week Low | $282.84 | $237.77 |
Dividend Yield | 1.77% | 2.2% |
Enterprise Value | — | $429.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase trades at $341.10, down 0.6% on the day, with a bullish technical signal from moving averages and support at $339. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $169.4B in 2024 to $181.8B in 2025. Analyst consensus is Moderate Buy with a $374 price target, representing 9.6% upside potential. Recent news highlights CEO Jamie Dimon's economic warnings and upcoming Q1 earnings on April 14.
JPMorgan demonstrates solid fundamentals with consistent revenue growth and strong net income margins above 30%. The stock appears reasonably valued with a P/E of 14.6. Key risks include geopolitical tensions impacting banking operations and cybersecurity vulnerabilities from advanced AI systems. The bullish analyst sentiment and technical setup suggest potential for continued upside if earnings momentum persists.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% today, with strong bullish technical signals and consistent earnings beats. Revenue reached $447.57B in 2025, though net margins compressed to 2.68%. The company maintains robust cash flow from operations at $19.70B and announced a $2.32 dividend for H1 2026. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.
Outlook remains positive with analyst consensus targeting $466.41, representing ~11% upside. Key opportunities include aging demographics and tech-driven healthcare adoption. Risks involve regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish with 82.7% buy ratings, supporting long-term growth prospects amid sector tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
